9.930SEK-2.65%Mkt Cap: 466.72M SEKP/E: —Last update: 2026-06-01
Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly k…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap466.72M SEK
Enterprise Value445.09M SEK
Revenue (TTM)0 SEK
Gross Profit7.68M SEK
Net Income (TTM)-27.24M SEK
Revenue/Share0.0000 SEK
Last Price9.930 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2020
Employees11
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-51.00
PEG—
EV/EBITDA-21.57
EV/Revenue—
P/SInfinity
P/B0.52
EPS (TTM)-0.54
EPS (Forward)-0.20
52W Range
7.53036% of range14.12
52W High14.12 SEK
52W Low7.530 SEK
Profitability
Gross Margin56.73%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin-201.18%
ROE-4.09%
ROA-3.99%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-17.49M SEK
CapEx (TTM)43.19M SEK
FCF Margin—
FCF Yield—
Net Debt-11.89M SEK
Net Debt/EBITDA0.58
Balance Sheet
Debt/Equity0.00
Current Ratio2.09
Quick Ratio0.27
Book Value/Sh19.53 SEK
Cash/Share0.4380 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateNov 4, 2019
Pay Date—
Splits
Last Split1:10
Split DateMay 24, 2023
Analyst Consensus
Rating—
Target (Mean)14.00 SEK
Target Range14.00 SEK – 14.00 SEK
# Analysts1
Ownership
Shares Out.47.00M
Float40.40M
Insiders12.07%
Institutions21.70%
Technical
SMA 5010.74 (-7.6%)
SMA 2009.586 (+3.6%)
Beta0.64
S&P 52W Chg27.70%
Avg Vol (30d)153.33K
Avg Vol (10d)164.11K
Technical Indicators
RSI (14)42.3
MACD-0.1522
MACD Signal-0.0667
MACD Hist.-0.0855
BB Upper11.48 SEK
BB Middle10.79 SEK
BB Lower10.09 SEK
BB Width12.84%
ATR (14)0.6834 SEK
Vol Ratio (20d)4.11x